were respectively smaller than 1.5% and 2%, the β-expectation tolerance limits did not exceed 22 the acceptance limits of 10% and the relative expanded uncertainties were smaller than 5% for 23 all of the considered components. 24 2 A UHPLC method was obtained for the identification and quantification of these kind of 25 pharmaceutical preparations, which will significantly reduce analysis times and workload for 26 the laboratories charged with the quality control of these preparations. 27 28
Introduction 41 42
Pharmaceutical preparations containing paracetamol and/or non-steroidal anti-inflammatory 43 drugs (NSAID) as acetyl salicylic acid or ibuprofen, are frequently used. In Belgium these 44 preparations are often made in-house by the pharmacist. Often they are combined with anti-45 histaminics as diphenhydramin and pheniramin maleate and some other active components as 46 caffeine and codein. The antihistaminics are added in formulations for the symptomatic 47 
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The method validation was performed in accordance with the requirements of the ISO17025 163 guideline using the total error approach [26, [28] [29] [30] . 164 Therefore the spiked blank samples prepared in section 2.3.2 were prepared in triple and 165 analysed for three consecutive days. The concentrations of the spiked samples were back-166 calculated using the calibration lines, prepared as described in section 2.3.1., to determine the 167 linearity between theoretical and measured concentrations, the mean relative bias, the 168 repeatability, the intermediate precision and the β-expectation tolerance or total error intervals 169 at the 5% level. The initial screening tests were performed as described in section 2.2. 181
Visual inspection of the obtained chromatograms led to the conclusion that the best initial 182 separation was obtained using a mobile phase of methanol with the ammonium acetate buffer 183 and the Acquity BEH C18 column. This method was used as starting point for further method 184 optimisation. Figure 1 shows the corresponding chromatogram. 185 186
Optimisation of the method 187
From figure 1 it can be seen that phenylephrine is eluted with the void volume and that the 188 separation between acetyl salicylic acid and caffeine is not optimal. Therefore the initial 189 gradient was adapted by lowering the percentage of aqueous phase in the initial conditions, 190 keeping the initial conditions for one minute and going to a plateau of 50/50 buffer/methanol 191 in 8 minutes. These adaptations to the gradient let to a good separation (resolution > 1.5) for 192 all ten components as well as to an improvement in peak symmetry (0.80-1.30). In principle 193 the run time of the method could still be reduced, though we chose to keep it at 11 minutes in 194 order to obtain a more general applicable method. Keeping a longer run time and higher 195 resolutions improves the opportunity that a component present in a preparation that was not 196 taken into account during the method development, can be detected and quantified with the 197 same method. 198
The final gradient starts at 95% ammonium acetate buffer pH 4 and 5% methanol. The initial 199 conditions are kept for one minute, before going to a plateau of 50% buffer and 50% 200 methanol in nine minutes. The plateau is maintained for two minutes before returning to the 201 initial conditions. The gradient was linear and the flow was 0.50 ml/min. For all of the ten components four calibration standards were prepared in order to evaluate the 216 relationship between the area under the curve and the concentration. The linearity of the 217 relationship was evaluated for each of the components in a concentration range, covering the 218 normal range of concentrations obtained when analyzing pharmaceutical preparations. 219
The calibration curves were obtained using ordinary least-square linear regression and the 220 linearity was confirmed with the R² values and a quality coefficient [31]. A statistical approach based on the "total error" profiles was applied to validate the method. 227
As explained in section 2.3.2 spiked blank samples were prepared at three concentration 228 levels. Table 3 gives the exact concentrations of the 3 levels for each of the components. 229
Every sample was prepared in triple and analysed for three consecutive days. 230
The concentrations of the spiked samples were back-calculated using the calibration lines, 231 prepared as described in section 2.3.1., to determine the linearity between theoretical and 232 measured concentrations, the mean relative bias, the repeatability, the intermediate precision 233
and the β-expectation tolerance or total error intervals at the 5% level. All results are shown in 234 Accuracy takes into account the total error of the test results and is represented by the β-247 expectation tolerance intervals. The acceptance limits for the bias were set at 10 %. This is 248 based on the fact that the general acceptance limits for the content of pharmaceutical 249 preparations, made by a pharmacist, are from 90 to 110%. As shown in table 4 and figure 3 250 the relative β-expectation tolerance intervals did not exceed the acceptance limits, which 251 means that each future measurement of unknown samples will be included in the tolerance 252 limits for the relative bias at the 10% level. The test was performed by a 3-factor 3-level full factorial design, with the flow, the column 283 temperature and the pH of the ammonium acetate buffer as factors and the resolution between 284 caffeine and acetyl salicylic acid (critical pair) as response. The different levels were chosen13 based on the errors which are common during such an analysis. Table 7 shows the 286 experimental design performed and the corresponding resolutions obtained. All experiments 287 were performed in random order. 288
The effects of the different factors were calculated and their significance at the 5% level was 289 tested by ANOVA analysis. Table 8 From the ANOVA analysis it could be seen that the regression is significant with an R 2 of 294 99.99%. From figure 4 and 5 and from the ANOVA table shown in Table 9 it could be seen 295 that the temperature and the flow have a small significant effect on the resolution between 296 caffeine and acetyl salicylic acid. The pH has a strong effect on the resolution between those 297 two components. The effects of the temperature and the flow could be explained by the fact 298 that UHPLC works with very high pressure. Little changes in temperature and flow cause an 299 important change in the pressure, which influences retention and resolution. The strong effect 300 of the pH on the resolution of the critical pair can be explained by the fact that pH 4.0 is close 301 to the pK a value of acetyl salicylic acid. Comparing the different chromatograms obtained 302 under the different conditions revealed that the retention time of acetyl salicylic acid changes 303 strongly in function of the pH, while the shifts in retention times of the other components are 304 less significant. 305
Eventhough it was statistically proven that the pH, the temperature and the flow have 306 significant effects on the resolution of the critical pair, this does not influence the quality of 307 the method since the resolution of the critical pair stays always higher than 1.5 (Table 7) . The 308 method can be considered as suited for purpose. 309 qualitative and quantitative analysis of pharmaceutical preparations containing a series of 313 non-steroidal anti-inflammatory drugs in combination with anti-histaminics and/or caffeine 314 and codein phosphate. The validation was performed following the ISO17025 requirements 315 and proved that the method was suited for purpose and can be used in the routine analysis of 316 these pharmaceutical preparations. 317
The method is a gradient method, using a 0.025 M ammonium acetate buffer of pH 4.0 as 318 aqueous phase and methanol as organic phase. The gradient starts at a percentage of 95% of 319 the buffer solution and comes to a plateau of 50% buffer at 9 minutes. The flow rate is 0.5 320 ml/min and the detection wavelength 254 nm. 321
The method was applied in the analysis of routine samples at our lab and showed a good 322 performance. Depending on the composition of the sample the gradient could even be 323 shortened in order to gain time and solvents. When the composition allowed it the method 324 was also used in our laboratory to dose preparations containing ibuprofen, chlorphenamine 325 maleate, metoclopramide, etc… , broadening the applicability of the method to preparations 326 composed of other combination of non-steroidal anti-inflammatory drugs and anti-327 histaminics. When using the method for other molecules as described in this paper, one 328 should always check the method for the APIs in the preparation first. 329
The fact to have a general applicable method that allows the analysis of the majority of the 330 NSAID pharmaceutical preparations in a run time of twelve minutes represents a significant 331 
